Company Analysis

Allarity Therapeutics, Inc. (ALLR)

Nasdaq: ALLR · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2021
Grade3.4
◀ Past 2.4● Present 1.8▶ Future 5.4
4 est.

Who runs Allarity Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Jensen Thomas
CEO. First filing Dec 2021, latest May 14, 2026, 0 filings in all.
Officers reporting now
3
of 5 people with a filing in the last fifteen months
Directors reporting now
2
18 people on the record since 2021
Officerssales are open-market, Oct 9, 2025 to Oct 9, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Graff Jeremy R.See RemarksSep 2024Oct 9, 2026none
Jensen ThomasCEODec 2021May 14, 2026none
Ervin Jeffrey SCFOJul 2025Apr 30, 2026none
Directorssales are open-market, Oct 9, 2025 to Oct 9, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hoeiland JesperdirectorJan 2026May 11, 2026none
Mclaughlin Gerald W.directorOct 2022May 7, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ALLR · research, not advice